{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:50:46Z","timestamp":1768319446354,"version":"3.49.0"},"reference-count":32,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2012,3,14]],"date-time":"2012-03-14T00:00:00Z","timestamp":1331683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Viral suppression by antiretroviral therapy (<jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>) inhibits <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010induced apoptosis and <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4 <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\u2010cell loss. It has been suggested that protease inhibitors (<jats:styled-content style=\"fixed-case\">PIs<\/jats:styled-content>) have nonviral antiapoptotic effects by maintaining mitochondrial integrity. Long\u2010term clinical effects of <jats:styled-content style=\"fixed-case\">PI<\/jats:styled-content>\u2010based <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> on mitochondrial toxicity and lymphocyte apoptosis beyond viral suppression have not been exploited to date.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a 7\u2010year study on <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u20101\u2010infected patients from the <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>ologne <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> cohort with sufficient viral suppression under either a <jats:styled-content style=\"fixed-case\">PI<\/jats:styled-content>\u2010based or nonnucleoside reverse transcriptase inhibitor (<jats:styled-content style=\"fixed-case\">NNRTI<\/jats:styled-content>)\u2010based regimen. Eight patients on <jats:styled-content style=\"fixed-case\">PI<\/jats:styled-content> and eight on <jats:styled-content style=\"fixed-case\">NNRTI<\/jats:styled-content> were eligible for inclusion in the analysis. The primary outcome measure was defined as a change in the mitochondrial\u2010to\u2010nuclear <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content> ratio in <jats:styled-content style=\"fixed-case\">PBMCs<\/jats:styled-content>. Further key molecules involved in extrinsic [tumour necrosis factor\u2010related apoptosis\u2010inducing ligand (<jats:styled-content style=\"fixed-case\">TRAIL<\/jats:styled-content>), Fas ligand (<jats:styled-content style=\"fixed-case\">FasL<\/jats:styled-content>) and caspase 8], intrinsic [<jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>\u2010cell lymphoma 2 (<jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>cl\u20102), <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>cl\u20102\u2010associated <jats:styled-content style=\"fixed-case\">X<\/jats:styled-content> protein (<jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>ax), caspase 9 and lactate\u2010to\u2010pyruvate ratio] and overall apoptosis [<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>nnexin+\/7\u2010aminoactinomycin <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content> (7\u2010<jats:styled-content style=\"fixed-case\">AAD<\/jats:styled-content>)\u2013 and caspase 3\/7] and viral activity [negative regulatory factor (<jats:styled-content style=\"fixed-case\">N<\/jats:styled-content>ef), interferon\u2010\u03b1 (<jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b1) and myxovirus resistance protein A (<jats:styled-content style=\"fixed-case\">MxA<\/jats:styled-content>)] were measured.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Demographic and baseline clinical parameters were similar in the two groups, except that patients in the <jats:styled-content style=\"fixed-case\">PI<\/jats:styled-content> group had a higher mean age. After 7 years of treatment, <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4 <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>\u2010cell count increased and the expression of genes encoding the proapoptotic viral protein <jats:styled-content style=\"fixed-case\">N<\/jats:styled-content>ef and <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010induced cytokine <jats:styled-content style=\"fixed-case\">IFN<\/jats:styled-content>\u2010\u03b1 and its downstream effector <jats:styled-content style=\"fixed-case\">MxA<\/jats:styled-content> decreased in both groups. Focusing on the different pathways of apoptosis, only in the <jats:styled-content style=\"fixed-case\">PI<\/jats:styled-content> group intrinsic apoptosis decreased significant and in the inter\u2010group comparison the decrease was significantly higher than in the <jats:styled-content style=\"fixed-case\">NNRTI<\/jats:styled-content> group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study provides evidence that long\u2010term therapy with a <jats:styled-content style=\"fixed-case\">PI<\/jats:styled-content>\u2010based regimen may be superior to that with a <jats:styled-content style=\"fixed-case\">NNRTI<\/jats:styled-content>\u2010based regimen with regard to its intrinsic antiapoptotic effect.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2012.00999.x","type":"journal-article","created":{"date-parts":[[2012,3,14]],"date-time":"2012-03-14T04:22:23Z","timestamp":1331698943000},"page":"469-478","source":"Crossref","is-referenced-by-count":5,"title":["Long\u2010term beneficial effect of protease inhibitors on the intrinsic apoptosis of peripheral blood mononuclear cells in <scp>HIV<\/scp>\u2010infected patients"],"prefix":"10.1111","volume":"13","author":[{"given":"N","family":"Jung","sequence":"first","affiliation":[{"name":"First Department of Internal Medicine Medical Hospital of the University of Cologne  Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Lehmann","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine Medical Hospital of the University of Cologne  Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Knispel","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Medical Hospital of the University of Cologne  Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EK","family":"Meuer","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine Medical Hospital of the University of Cologne  Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Fischer","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine Medical Hospital of the University of Cologne  Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"F\u00e4tkenheuer","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine Medical Hospital of the University of Cologne  Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Hartmann","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine Medical Hospital of the University of Cologne  Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Taubert","sequence":"additional","affiliation":[{"name":"Department of Pharmacology Medical Hospital of the University of Cologne  Cologne Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,3,14]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000216375.99560.a2"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f7cb76"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302043280508"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-009-0314-1"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-79437-7_13"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2010.526602"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-007-0755-3"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200305020-00007"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki172"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912163412501"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012035"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000385"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.9.e45"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.062901"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112453"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833c93ce"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401580"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401584"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2009.01006.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2006.09.016"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.20223"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.070490"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.4.2.1508"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.2174\/157340608783331443"},{"key":"e_1_2_6_26_1","first-page":"2025","article-title":"HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice","volume":"118","author":"Hisatomi T","year":"2008","journal-title":"J Clin Invest"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-1230com"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI22954"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401289"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1086\/651689"},{"key":"e_1_2_6_31_1","unstructured":"Guidelines for the use of antiretroviral agents in HIV\u20101\u2010infected adults and adolescents \u2013 January 10.2011.DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents \u2013 A Working Group of the Office of AIDS Research Advisory Council (OARAC). Available at%20http:\/\/aidsinfo.nih.gov\/Guidelines\/GuidelineDetail.aspx?GuidelineID=7&ClassID=1(accessed 10 October 2011)."},{"key":"e_1_2_6_32_1","article-title":"Therapeutic targeting of apoptotic pathways: novel aspects in pancreatic cancer","author":"Neesse A","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.225"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2012.00999.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2012.00999.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T16:41:55Z","timestamp":1700584915000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2012.00999.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,14]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.1111\/j.1468-1293.2012.00999.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2012.00999.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,14]]}}}